Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print November 16, 2006
DOI: 10.2337/db06-1165

This Article
Right arrow Full Text (Diabetes Publish Ahead of Print (PDF))
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db06-1165v1
56/1/3    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chase, L. G.
Right arrow Articles by Verfaillie, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chase, L. G.
Right arrow Articles by Verfaillie, C. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Received for publication 17 August 2006
Accepted in revised form 6 October 2006

Islet-Derived Fibroblast-Like Cells Are Not Derived Via Epithelial-Mesenchymal Transition From Pdx-1 or Insulin-Positive Cells

Lucas G. Chase 1 , Fernando Ulloa-Montoya 1 , Benjamin L. Kidder 1 , and Catherine M. Verfaillie 1

From the 1 Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota.

As recent studies suggest that newly formed pancreatic {beta}-cells are a result of self-duplication rather than stem cell differentiation, in vitro expansion of {beta}-cells presents a potential mechanism by which to increase available donor tissue for cell-based diabetes therapies. Although most studies have found that {beta}-cells are resilient to substantial in vitro expansion, recent studies have suggested that it is possible to expand these cells through a process referred to as epithelial-mesenchymal transition (EMT). To further substantiate such an expansion mechanism, we used recombination-based genetic lineage tracing to determine the origin of proliferating fibroblast-like cells from cultured pancreatic islets in vitro. We demonstrate, using two culture methods, that EMT does not underlie the appearance of fibroblast-like cells in mouse islet cultures but that fibroblast-like cells appear to represent mesenchymal stem cell (MSC)-like cells akin to MSCs isolated from bone marrow.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
Y. Bar, H. A. Russ, S. Knoller, L. Ouziel-Yahalom, and S. Efrat
HES-1 Is Involved in Adaptation of Adult Human {beta}-Cells to Proliferation In Vitro
Diabetes, September 1, 2008; 57(9): 2413 - 2420.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Billestrup and T. Otonkoski
Dedifferentiation for Replication of Human {beta}-Cells: A Division Between Mice and Men?
Diabetes, June 1, 2008; 57(6): 1457 - 1458.
[Full Text] [PDF]


Home page
DiabetesHome page
H. A. Russ, Y. Bar, P. Ravassard, and S. Efrat
In Vitro Proliferation of Cells Derived From Adult Human {beta}-Cells Revealed By Cell-Lineage Tracing
Diabetes, June 1, 2008; 57(6): 1575 - 1583.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
Y. Dor and B. Z. Stanger
Regeneration in Liver and Pancreas: Time to Cut the Umbilical Cord?
Sci. Signal., November 27, 2007; 2007(414): pe66 - pe66.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.